Navigation Links
How tumor cells move
Date:4/8/2009

If cancer cells lack a certain protein, it could be much easier for them to penetrate healthy body tissue, the first step towards forming metastases. Scientists at the Pharmacology Institute of the University of Heidelberg have discovered the previously unknown cell signal factor SCAI (suppressor of cancer cell invasion), which inhibits the movement and spread of tumor cells in laboratory tests. When the factor's functioning was disrupted, the cancer cells moved much more effectively in what are known as three-dimensional matrix systems, which imitate some of the tissue properties of the human body.

"The protein is apparently suppressed in many types of tumors, e.g. breast, lung, or thyroid," explains Dr. Robert Grosse, head of the Emmy Noether Junior Research Group funded by the German Research Association (DFG) at the Pharmacology Institute. The new factor could be an interesting starting point for research into new mechanisms for fighting cancer. The research team's results have now been published online in the prestigious international journal Nature Cell Biology.

Focus on particularly aggressive cancers

Tumor cells are extremely mobile and "adept" at penetrating healthy tissue to form metastases. They adapt to the consistency of the respective tissue by changing their shapes constantly and attach flexibly to surrounding tissues during movement with the help of special surface structures (receptors).

One of these receptors is what is known as b1-integrin, which is frequently formed in many tumors such as metastasizing breast cancer. "The cell signal factor SCAI controls the formation and function of b1-integrin," says Dr. Robert Grosse. "If there is too little SCAI in tumor cells, then b1-integrin is overactive, so to speak. The cell can change more rapidly to a more aggressive form and penetrate surrounding tissue, a crucial step toward increased spreading of the tumor and the possible formation of meta
'/>"/>

Contact: Dr. Robert Grosse
robert.grosse@pharma.uni-heidelberg.de
49-062-215-48619
University Hospital Heidelberg
Source:Eurekalert

Page: 1 2

Related biology news :

1. University of Kansas graduate student researcher takes aim at deadly brain tumors
2. Skin cancer study uncovers new tumor suppressor gene
3. Regulatory molecule for tumor formation or suppression identified by Singapore, US researchers
4. New tumor markers determine therapy intensity
5. Freezing kidney cancer: Hot treatment should be new gold standard for destroying small tumors
6. Tiny tool to control growing blood vessels opens new potential in tumor research
7. Researchers isolate protein domain linked to tumor progression
8. Singapore research organisations team up to advance drug discovery using brain tumor stem cells
9. Scattered light rapidly detects tumor response to chemotherapy
10. New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome
11. Stress may hasten the growth of melanoma tumors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...urns out, hold the power to help militaries and mu...n up toxic waste on test sites. , Compounds know...ack in World War II and have been used in military...ds are often used to propel tank shells and act li...increased knowledge of their environmentally harmf...
(Date:11/4/2009)...re-FirstCall/ -- Quest Diagnostics Incorporated (N...ostic testing, information and services, announced...09, income from continuing operations rose to $192...llion, or $0.81 per diluted share, for the third q...e reduced by a $0.03 per share charge associated w...
(Date:11/4/2009)...swire/ -- GenVault Corporation, the leader in ambi...iscovery, medicine and identification, today annou...t and CEO, will be presenting at the BIOCOM Invest...h in La Jolla, CA. ,, During the presentation, ... together with recent customer, technical and stra...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Sysmex America Names Industry Veteran to Business Development Post 51339 1Sysmex America Names Industry Veteran to Business Development Post 51339 2NOSCAR 28R 29 Announces NOTES 28R 29 Multicenter Human Trials in the U S 51337 1NOSCAR 28R 29 Announces NOTES 28R 29 Multicenter Human Trials in the U S 51337 2NOSCAR 28R 29 Announces NOTES 28R 29 Multicenter Human Trials in the U S 51337 3ECCO 15 ESMO 34 multidisciplinary cancer congress 51335 1ECCO 15 ESMO 34 multidisciplinary cancer congress 51335 2
...w study has found that the allergenicity of peanut...ial fermentation process. Researchers from North C...oday at the 105th General Meeting of the American ...f peanuts in food products such as cookies, snacks...ut allergens to protect consumers from a potential...
...lts advance quest for viral-based therapies for ca... Center continue to make strides in their work to ...ed therapies for cancer. Two papers about promisi...udied in mice, published today in the journals Can...cademy of Sciences (PNAS), bring us significantly ...
...nt research suggested that ancient Neanderthals mi...that of modern humans but that seems flawed, based...e University and the University of Newcastle . , ...n the Neanderthal fossils they examined was compar...ern humans. , And since the rate of tooth growth...
Other Biology News:Columbia scientists develop cancer terminator viruses 2Columbia scientists develop cancer terminator viruses 3Neanderthal teeth grew no faster than comparable modern humans' 2Neanderthal teeth grew no faster than comparable modern humans' 3
(Date:11/6/2009)...genda for Arrowhead’s 2010 Personalized Medi... place on February 22-24, 2010 in Philadelphia, ha...will highlight key issues in forming partnerships ...ences. , Minneapolis, MN ...ad’s 2010 Personalized Medicine Partnership...
(Date:11/5/2009)... DSM Pharmaceutical Products today ...e with Galenix, Saint Jean D,Illac, France, where ...turing partner for Galenix commercial products on ...rate on business development opportunities co-mark... the strength of Galenix in drug product developme...
(Date:11/5/2009)...wswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulle... for the quarter ended September 30, 2009. The Com...es that follow. ,, Third Quarter 2009 ,, T...1 per share for the third quarter of 2009 as compa...or the third quarter of 2008. ,, Net sales wer...
(Date:11/5/2009)..., 2009 Senomyx, Inc. (Na...ary taste receptor-based technologies to discover ...nd ingredient supply industries, today provided a ...r the third quarter ended September 30, 2009. Rev...009, compared to $4.0 million for the third quarte...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...what hed like to be doing if he wasnt in informati...nsultant was his quick answer. , ,It shows in his ...ets the technology and its potential for business ... the business than the technology. , , Stockhause...Peter and his IT shop begin talking IT solutions, ...
...ng it out with Los Angeles for second place in the...ter, Chicago,s business community is finite. , ,In...orld phenomenon holds even more true. It therefore... even smaller. People know one another. This is a ...comes of spending some years working in the Midwes...
... with STI Knowledge, an Atlanta-based provider of ...ny Data is a BPO company with offices in Norristow...d, India. Symphony Data was spun off from its pare...f healthcare administrative and BPO services, with...d insurance industries. , ,"We are extremely pleas...
Other Biology Technology:Peter Stockhausen: CIO or business consultant? 2Peter Stockhausen: CIO or business consultant? 3Peter Stockhausen: CIO or business consultant? 4How name-dropping can make interviews fail 2How name-dropping can make interviews fail 3How name-dropping can make interviews fail 4
Mouse Anti-Human IFNA13 Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-SF3B2 Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human UGT2B10 Monoclonal Antibody, Unconjugated, Clone 2D9 from Novus Biologicals
...t is a sample preparation kit for reduction of str...lic compounds, salts, and most other ionic contami...t procedure involves a TCA-like precipitation. Rec...r cells, plant leaves, E. coli, and yeast. The kit...
Biology Products: